MedPath

Gut-Brain-Axis Therapeutics Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

Phase 2
Not yet recruiting
Conditions
Autism Spectrum Disorder
Constipation
Gastro-Intestinal Disorder
Diarrhea
First Posted Date
2024-07-16
Last Posted Date
2024-07-16
Lead Sponsor
Gut-Brain-Axis Therapeutics Inc.
Target Recruit Count
60
Registration Number
NCT06503978
Locations
🇺🇸

Autism/Asperger's Research Group at Arizona State University, Tempe, Arizona, United States

Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

Phase 2
Recruiting
Conditions
Pitt Hopkins Syndrome
First Posted Date
2024-03-20
Last Posted Date
2024-03-20
Lead Sponsor
Gut-Brain-Axis Therapeutics Inc.
Target Recruit Count
20
Registration Number
NCT06321796
Locations
🇺🇸

Autism/Asperger's Research Group at Arizona State University, Tempe, Arizona, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.